Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,6843 USD | -2,24% | +3,52% | -7,90% |
Omzet 2024 * | 5,59 mln. 5,23 mln. | Omzet 2025 * | 3,67 mln. 3,43 mln. | Marktkapitalisatie | 37,41 mln. 34,99 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -63 mln. -58,92 mln. | Nettowinst (verlies) 2025 * | -66 mln. -61,73 mln. | EV/omzet 2024 * | 4,83 x |
Nettoliquiditeiten 2024 * | 10,4 mln. 9,73 mln. | Nettoschuld 2025 * | 29,1 mln. 27,22 mln. | EV/omzet 2025 * | 18,1 x |
K/w-verhouding 2024 * |
-0,63
x | K/w-verhouding 2025 * |
-0,67
x | Werknemers | 55 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 85,57% |
Recentste transcriptie over Cara Therapeutics, Inc.
1 dag | -2,24% | ||
1 week | +3,52% | ||
Lopende maand | -24,80% | ||
1 maand | -6,29% | ||
3 maanden | +18,70% | ||
6 maanden | -40,50% | ||
Lopend jaar | -7,90% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 54 | 06-08-18 | |
Ryan Maynard
DFI | Director of Finance/CFO | 54 | 12-09-22 |
Scott Terrillion
CMP | Compliance Officer | 61 | 01-11-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Martin Vogelbaum
CHM | Chairman | 60 | 01-07-10 |
Jeffrey Ives
BRD | Director/Board Member | 73 | 16-07-14 |
Helen Boudreau
BRD | Director/Board Member | 58 | 02-08-23 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
11.20% | 35 M€ | +18,97% | - | |
1.29% | 13 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 0,6843 | -2,24% | 169 234 |
25-04-24 | 0,7 | +4,23% | 319 087 |
24-04-24 | 0,6716 | -5,02% | 217 430 |
23-04-24 | 0,7071 | -3,19% | 181 920 |
22-04-24 | 0,7304 | +10,50% | 346 171 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-7,90% | 37,41 mln. | |
-4,66% | 86,13 mld. | |
+1,32% | 39,82 mld. | |
-19,27% | 30,42 mld. | |
+57,86% | 25,23 mld. | |
-17,69% | 11,6 mld. | |
-43,00% | 11,51 mld. | |
-9,14% | 11,95 mld. | |
+5,24% | 8,71 mld. | |
-8,42% | 8,12 mld. |